Pharmacology and Mechanism of Action
Etomidate (Etomidatum) is a chemical compound belonging to the carboxylated imidazole group. In clinical practice, it is primarily used for induction of general anesthesia or balanced anesthesia.
The key mechanism of action involves potentiating GABA (gamma-aminobutyric acid) effects in the central nervous system. Through this mechanism, etomidate shares similarities with another popular intravenous anesthetic, propofol.
Administered intravenously, the drug exhibits high pharmacological potency and is classified as an ultra-short-acting agent. It reliably induces unconsciousness for just 3 to 5 minutes. During anesthesia, two important hemodynamic and neurological aspects must be considered:
- A potential decrease in blood pressure (hypotension).
- Spontaneous muscle movements may occur during the anesthetic procedure.
Analgesic Profile
A critical pharmacodynamic feature of etomidate is the complete absence of analgesia.
Despite its high potency in suppressing consciousness, the drug does not block pain signals. This makes it unsuitable as a sole agent for surgical procedures. To provide adequate surgical anesthesia, etomidate must be combined with analgesics, typically opioids.
Side Effects and Endocrine Toxicity
The use of etomidate is associated with several adverse effects. The most common postoperative clinical manifestation is frequent nausea and vomiting, the risk of which increases significantly when the drug is co-administered with opioid analgesics.
A key characteristic of etomidate is its specific endocrine toxicity. The drug selectively inhibits steroidogenesis in the adrenal cortex. Even after a single intravenous dose, plasma levels of vital hormones significantly decrease:
- Hydrocortisone (cortisol);
- Aldosterone.
This property imposes strict limitations on the duration of its administration. The risks of prolonged infusion are associated with the development of acute adrenocortical insufficiency. The clinical presentation of this complication includes:
- Persistent hypotension.
- Marked electrolyte imbalances.
- Oliguria (decreased urine output).